Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05750745Completed
Randomised, single-blind trial of stannous fluoride in dentin hypersensitivity (DH) (3 arms), sponsored by Haleon. Primary endpoint: Adjusted Mean Change From Baseline in Schiff Sensitivity Score at 12 weeks. Started May 2023; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05750745.